When was ViaLase founded?

ViaLase was founded in 2018 and raised its 1st funding round 6 years after it was founded.

Where is ViaLase located?

ViaLase is headquartered in Newport Beach, United States.

How many employees does ViaLase have?

As of Sep 30, 2026, the latest employee count at ViaLase is 34.

Is ViaLase a funded company?

ViaLase is a funded company, having raised a total of $45.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jan 05, 2024.

When was the latest funding round of ViaLase?

ViaLase's latest funding was a $***** Series C round on Mar 25, 2024, with participation from 3 investors.

Where does ViaLase rank among its competitors?

ViaLase ranks 1st amongst 9 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was LightTouch, which secured $25K in Jul, 2025.

Who are the top competitors of ViaLase?

ViaLase's top competitors include BELKIN Vision, Radiance Therapeutics and ELIOS Vision. Among them, LightTouch secured the most recent funding round in July, 2025.

ViaLase - 2026 Company Profile, Funding & Competitors

ViaLase is a series C company based in Newport Beach (United States), founded in 2018. It operates as a Developer of image-guided devices for glaucoma treatments. ViaLase has raised $45.2M in funding from investors like Venture Investors, Arboretum Ventures and Falcon-Vision. The company has 9 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like BELKIN Vision, Radiance Therapeutics and ELIOS Vision.

Company Details

Developer of image-guided devices for glaucoma treatments. The company focuses on the development of an image-guided femtosecond laser surgical system for the treatment of glaucoma.

Key Metrics

Founded Year

2018

Location

Newport Beach, United States

Stage

Series C

Total Funding

$45.2M in 2 rounds

Latest Funding Round

Series C, Mar 25, 2024, $*****

Investors

Venture Investors & 2 more

Ranked

1^st among 9 active competitors

Employee Count

34 as on Sep 30, 2026

Similar Companies

BELKIN Vision & 8 more

View ViaLase's full profile

ViaLase has raised a total funding of $45.2M over 2 rounds. Its first funding round was on Jan 05, 2024. Its latest funding round was a Series C round on Mar 25, 2024 for $*****. 3 investors participated in its latest round. ViaLase has 3 institutional investors.

Here is the list of recent funding rounds of ViaLase:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 25, 2024	9767368	Series C	5537264	2635993	8305018	9038787
Jan 05, 2024	9301360	Conventional Debt	1940407	1707316	9323481	7166735

Access funding benchmarks and valuations. Sign up today!

View details of ViaLase's funding rounds and investors

ViaLase's employee count trend

ViaLase has 34 employees as of Sep 26. Here is ViaLase's employee count trend over the years:

Uncover ViaLase's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ViaLase include BELKIN Vision, Radiance Therapeutics and ELIOS Vision. Here is the list of Top 10 competitors of ViaLase, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ViaLase 2018, Newport Beach (United States), Series C	Developer of image-guided devices for glaucoma treatments	$45.2M	Arboretum Ventures, Venture Investors & 1 others	55/100
2nd	BELKIN Vision 2013, Yavne (Israel), Acquired	Developer of a laser device for the treatment of glaucoma	$16.2M	Rimonci, ZIG Ventures & 6 others	39/100
3rd	Radiance Therapeutics 2018, Oro Valley (United States), Series B	Developer of beta ophthalmic applicator for glaucoma	$14M	Checkmate Capital, Heaven11	38/100
4th	ELIOS Vision 2019, Los Angeles (United States), Acquired	Developer of therapy device for glaucoma and lower eye pressure	-	Exsight Ventures	31/100
5th	LightTouch United States, Seed	Developer of investigational device technology for measuring eye pressure accurately	$25K	-	26/100
6th	ICRCAT 1986, Barcelona (Spain), Unfunded	Chains providing comprehensive medical and surgical treatments for eye conditions	-	-	23/100
7th	EyeLight Innovations Unfunded	Developer of visualization systems for performing laser based glaucoma surgery	-	-	16/100
8th	MD Lasers Pleasanton (United States), Unfunded	Manufacturer of medical lasers, instruments, eye surgery lasers, and accessories	-	-	16/100
9th	EthosVision 2003, Unfunded	Ethos Anti-Aging Bright Eyes & Carnosine	-	-	16/100
10th	EyeLight 2004, Carlsbad (United States), Deadpooled	Deevloper of patented treatment method for glaucoma	-	-	15/100